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Abstract
The present paper reports data regarding the influence of aluminum, at micromolar concentrations, on intracellular
3q 2q  . 2qcalcium homeostasis. Al modifies Ca uptake in the endoplasmic reticulum ER , accelerates Ca release from
mitochondria and strongly inhibits Ca2q-ATPase activity with a consequent high-level calcium accumulation inside the cell.
These results suggest that Al3q neurotoxicity may be related to an alteration of the intracellular calcium regulatory system.
q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
w xAluminum is a well known neurotoxic agent 1–3 .
However, the molecular mechanisms underlying the
detrimental effects caused by the metal ion have yet
to be fully understood. Aluminum has been strongly
implicated in the etiopathogenesis of dialysis demen-
tia of uremic subjects who undergo long-term dialysis
w xtreatment 4 and as a hypothetical factor or co-factor
in the development of certain progressive and eventu-
w xally fatal neuropathologies 5 . For example, in the
systemic degenerative disease like amyotrophic lat-
eral sclerosis, a high concentration of Al3q, was
reported to positively correlate with calcium levels in
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the degenerated area of the CNS leading to the idea
that calcium homeostasis could be compromised by
3q w xAl 6 .
A calcium hypothesis in aging brain and
 .Alzheimer’s disease AD was first hypothesized in
w x1982 and recently reviewed 7 . A significant loss of
parvalbumin-positive cells was found in the frontal
w xand temporal cortex 8 of AD brain samples together
with a significantly lower concentration of the cal-
cium-dependent proteins calmodulin and calbindin
28K. Epilepsy has also been associated with a large
w xinflux of calcium into nerve cells 9 . In rats, a
deficiency of calcium and magnesium can facilitate
accumulation of aluminum in the CNS with concomi-
tant neuronal disintegration and proliferation of glial
w xcells 10 . In addition, increased calcium uptake has
been described in rat brain after administration of
w xaluminum lactate 10 . These findings indicate that
aluminum may play a role in triggering calcium
w xincrease in the CNS 11,12 . Finally, it has been
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reported that Al3q accumulates in human brain as an
aging related phenomenon at a rate of 6 mg of metal
w xion per year of life 13 .
These observations prompted us to study the possi-
ble destructive effect of Al3q on intracellular calcium
homeostasis. This report demonstrates that Al3q can
influence calcium uptake in the endoplasmic reticu-
 . 2qlum ER , accelerate the release of Ca from mito-
chondria and inhibit the Ca2q-ATPase pump. These
effects together with the recent demonstration that
3q q q w xAl can activate the Na rK -ATPase pump 14 ,
reinforce the hypothesis that Al3q is either directly or
indirectly able to disrupt Ca2q homeostasis, with
potential and neuropathological consequences.
2. Materials and methods
2.1. Preparation of aluminum solutions
Aluminum solutions were prepared as described in
w xdetail elsewhere 14 . Briefly, a 10-mm aluminum
lactate solution prepared in Tris–HCl buffer, pH 7.5,
ms0.1, was centrifuged and then passed through a
0.2-mm Millipore microfilter to eliminate all precipi-
 . 3qtated Al OH . The Al concentration in the result-3
ing clear solution was determined either colorimetri-
w xcally 15 or by atomic absorption spectrophotometry
w x16 .
2.2. Preparation of cellular organelles
Mitochondria were prepared from Wistar rat
 .Harlan, Udine, Italy liver as described in detail
w xelsewhere 17 , and ER, also from Wistar rat liver,
was prepared following the method described by
w xColbeau et al. 18 . Protein concentration was deter-
w xmined according to Lowry et al. 19 .
2.3. Ca2q-ATPase assay
The enzymatic activity was measured spectropho-
tometrically at 340 nm in an assay mixture containing
50 mM CaCl , 120 mM KCl, 0.2% Triton X-100, 302
mM HEPES buffer, pH 7.4, 0.5 mM MgCl , 0.5 mM2
Na-ATP, 0.2 mM NADH, 0.5 mM phosphoenolpyru-
vate, 0.81 IUrml pyruvate kinase, and 0.8 IUrml
lactate dehydrogenase final concentrations. The assay
was started by adding 100 ml of sample to arrive at a
final volume of 1 ml, and incubated in a thermostatic
bath at 378C. Absorbance variation was spectrophoto-
metrically recorded in the first 4 min. The reaction
 .was stopped by adding 2 mM final concentration of
ethylenediaminetetraacetic acid sodium salt Na-
.EDTA . The enzymatic activity was then calculated
by subtracting the slope of the curve obtained in the
presence of Na-EDTA from the initial slope.
Thapsigargin, a plant-derived sesquiterpene lac-
tone that is known to selectively inhibit the endo-
w xsarcoplasmic reticular calcium ATPase pump 20,21 ,
was purchased from MolecularProbes Leiden, Hol-
.land .
2.4. Ca2q transport through the mitochondrial
membrane
 . 2qCalcium-Green 5N MolecularProbes is a Ca
indicator that increases its fluorescence when com-
w x plexed with calcium 22,23 K s29 mM at pH 6.8d
. and 308C; K s10 mM at pH 7.2 and 258C F.d
.Ricchelli, personal communication .
Ca2q transport through the mitochondrial mem-
brane was evaluated as described by Becker et al.
w x24 in the buffered solution containing 125 mM KCl,
4 mM MgCl , 2 mM KH PO , 25 mM HEPES, 42 2 4
mM rotenone, 5 mM succinate and 3 mM ATP final
concentrations. Succinate was the source of energy
for Ca2q transport into the mitochondria. The ionic
composition of the medium simulates that of the
q cytoplasm with respect to the content of K 125
. 2q  .  .mM , Mg -ATP 3 mM , phosphate 2 mM and
2q  .free Mg 1 mM . Experiments were initiated by
adding the fluorescence indicator Calcium-Green 5N
 . 0.5 mM and 10 ml of mitochondria suspension 150
.mgrml protein and incubated at 258C. Calcium-
Green 5N was excited at 480 nm and the emission
was observed at 530 nm using a spectrofluorimeter
Perkin-Elmer LS 50B, with a thermostatically
equipped cell and a magnetic stirring device. The
fluorescence variation kinetics, reflecting the varia-
w 2qxtion in free Ca in the medium with respect to the
w 2qxinitial Ca as a contaminant, was followed using
the Time-Driver function of the spectrofluorimeter.
Fluorescence at various times was converted as free
w 2qxCa according to the following relationship:
FyFmin2qCa sKdfree F yFmax
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where K is a measure of the affinity of the probe, Fd
is the fluorescence of the indicator at different experi-
mental calcium levels, F is the fluorescence of themin
indicator in the absence of calcium and F is themax
fluorescence value of the calcium-saturated probe.
2.5. Measurements of Ca2q transport in the ER
Experiments were carried out at 308C and pH 6.8
w xusing an ER suspension 24 . Under these conditions
the ER calcium pump shows its maximal activity. In
the ER Ca2q transport assay, inhibitors of the mito-
chondrial respiratory chain and ATPases such as
 .  .antimycin A 0.2 mM and oligomycin 12.6 mM
were added to prevent possible Ca2q accumulation in
the mitochondria, which are present as a small con-
w xtaminant in the microsomal fraction 22 . Calcium-
 .Green 5N 0.5 mM was added to 2 ml of solution as
w xdescribed by Becker et al. 24 , followed by 20 ml of
 .ER suspension 50 mgrml protein , and fluorescence
at 530 nm was measured as described above, using
the spectrofluorimeter. Time-Driver function was used
w 2qxto evaluate the Ca variation in the medium. The
high calcium concentration in the medium was low-
ered by adding a 10-ml of 50 mM EGTA, a calcium
chelator, to avoid the immediate saturation of the
calcium pump, keeping in mind that the maximal free
w 2qxCa accumulation in the ER is very low. The
concentration of Ca2q both in ER and in mitochon-
dria was determined in the presence and in the ab-
sence of 50 mM Al3q.
2.6. Statistics
Data were analysed statistically using Student’s
t-test contained in the Statview statistical software
package for Macintosh computers. Unless specified
otherwise, each experiment was carried out three
times and in triplicate.
3. Results
[ 2q]3.1. Effect of aluminum on the homeostasis of Ca
in mitochondria
Fig. 1 reports mitochondrial Ca2q movement eval-
2q  .uated after adding Ca 0.8 mM and the fluorophor
Fig. 1. Calcium release from rat mitochondria described as
fluorescence of the Ca2q –Calcium-Green 5N complex vs. time.
In the assay, calcium is released more rapidly in the presence of
3q  .  .Al solid line compared to the controls dashed line .
Calcium-Green 5N to a mitochondrial suspension;
formation of Ca2q–fluorophor complex was moni-
tored spectrofluorimetrically. Results of this assay
demonstrate that Ca2q is internalized by mitochon-
dria, as evidenced by a rapid decrease in the fluores-
cence signal. An equilibrium between internal and
Fig. 2. Calcium pumping into the ER prepared from rat liver,
w 2q xreported as mM of Ca vs. time. Calcium pumping is greatly
3q  .reduced in the presence of Al I compared to the controls
 .  .v . Thapsigargin B completely inhibits calcium pumping, an
effect that is not significantly modified in the presence of Al3q
 .n .
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Fig. 3. Effect of Al3q on ER calcium-ATPase, reported as
 .enzyme activity mUrmg protein vs. metal ion concentration
 .mM . The curve exhibits an inhibitory saturation type phe-
nomenon dependent on Al concentration. Data represent the
average of three independent experiments carried out in triplicate.
external metal ion concentration is reached in about
1000 s. A further reduction in the fluorescence signal
is observed in the presence of the calcium chelator
EGTA, added to the assay to subtract Ca2q from the
medium in order to evaluate the Ca2q flux from
mitochondria. This phenomenon is extremely rapid
and is followed by a very slow release of Ca2q from
the mitochondria into the medium Fig. 1, dashed
Fig. 4. Effect of Al3q on mitochondrial calcium ATPase, re-
 . 3qported as enzyme activity mUrmg protein vs. Al concentra-
tion. The inhibitory phenomenon is dose-dependent. Experiments
were carried out three times and in triplicate.
. 3qline . Conversely, in the presence of 50 mM Al the
equilibrium is reached very rapidly, as evidenced by
an increase in fluorescence due to Ca2q-Calcium-
w 2qxGreen 5N complex formation when Ca is released
from mitochondria.
3.2. Effect of Al 3q on Ca2q mo˝ement in the ER
Fig. 2 shows the effect of Al3q on Ca2q uptake in
the ER. Ca2q movement was evaluated spectrofluori-
metrically on the basis of the formation of a complex
between Ca2q and Calcium-Green 5N.
In the presence of aluminum, Ca2q pump activity
is remarkably reduced. In the presence of the in-
hibitor thapsigargin, calcium pump activity in the ER
Fig. 5. Effect of Al on calcium ATPase activity mUrmg pro-
.  .  .tein from homogenate of rat brain A and cerebellum B . The
inhibition by Al3q is dose-dependent; data represent the average
of three independent experiments carried out in triplicate.
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is totally suppressed. To better understand how Al3q
interferes with calcium movement, assays were car-
ried out in the presence of both thapsigargin and
Al3q. Results showed that Al3q did not alter the
suppressive effect of thapsigargin on Ca2q pumping
 . 3qactivity Fig. 2 . This could indicate that Al and
thapsigargin act on the same Ca2q pump target. In
fact, as shown in Fig. 3, Al3q exerts a strong dose-
dependent inhibitory action on the ER calcium pump.
At 25 mM Al3q, the pump is inhibited by 50% and
the curve describes a saturation phenomenon.
Besides inhibiting ER Ca2q pump, Al3q also in-
hibits the mitochondrial Ca2q pump in a dose-depen-
 .dent manner Fig. 4 .
Al3q proved to be a good inhibitor of the Ca2q-
pump in all samples analysed, including Ca2q-ATPase
activity in rat brain and in cerebellum Fig. 5A and
.B and cell subparticle preparations.
4. Discussion
Intracellular calcium is regulated in a coordinated
manner through an antiport mechanism of NaqrKq
exchange in the plasma membrane and through dif-
ferent ATPases localized in the plasma membrane,
w x 2q qER and mitochondria 25 . Ca rNa antiporter ex-
change depends on the Naq gradient, which is regu-
lated by NaqrKq-ATPase; Al3q is able to activate
w x 2qsuch an ionic pump 26 . Ca storage inside the cell
is regulated by the ER compartment through second
w xmessengers 26 as a response to various stimulations
of receptor systems. Mitochondria regulate Ca2q
w xhomeostasis only transiently 25 by two separate
pathways, one Naq-dependent and the other Naq-in-
w xdependent 27 .
Mechanisms involved in cell injury and death have
been intensively investigated in recent years, with
many studies demonstrating that alteration of calcium
homeostasis can be a critical aspect of cytotoxicity
w x 3q28 . Experiments reported here demonstrate that Al
acts as an important disrupter of intracellular calcium,
interfering with different regulatory systems such as
those of the plasma membrane and ER membrane,
the mitochondrial Ca2q pump, as well as activating
q q w xNa rK -ATPase 14 . As illustrated in Table 1,
3q w 2qxAl can disrupt Ca homeostasis with conse-i
w x 3qquent detrimental effects 34 . Furthermore, Al has
also been reported to inhibit Ca2q accumulation in
the ER of myometrial cells, thus interfering with the
2q w x 3qactivity of the Ca pump 29 . Finally, Al has a
strong, pH-dependent effect on the voltage-activated
 .calcium channel current VACCC of cultured rat
dorsal root ganglion neurons, suggesting the exis-
tence of both intracellular and extracellular binding
3q w xsites for Al on VACCC 30,35 . In neuroblastoma
cells, Al3q has been observed to decrease the accu-
mulation of IP with a concomitant derangement of3
w 2qx w xCa homeostasis 32 . All these results are relevant
with regards to the accumulation of Al3q associated
w xwith aging 13 , and to the potential role of the metal
ion as a co-factor in certain neurological degenerative
w xpathologies 5 .
In this paper, we have demonstrated that Al3q can
modify the correct function of ER and mitochondrial
w 2qxsystems that regulate Ca homeostasis. Thus, dif-i
Table 1
Effects of aluminum on calcium homeostasis
Biological system Effects Refs.
2qCa -ATPase inhibition present paper
2qER Ca pump inhibition present paper
2qMitochondria increases Ca release present paper
q q w xNa rK -ATPase activation 14
2q w xMyometrial ER Ca pump inhibition 29
a w xVACCC irreversible blocker 30
w xCalmodulin binding 31
Pancreatic acinar cells:
2q w xReceptor-activated cytosolic Ca signal mediated by IP disruption 323
w xCalbindin vit. D-dependent-regulation inhibition 33
aVACCCsVoltage-activated calcium channel current.
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ferent and concomitant effects such as the inhibition
of ER Ca2q-pump activity and the rapid release of
Ca2q from mitochondria could produce a relevant
w 2qxmodification of Ca . This could in turn drive thei
cell towards pathways that are detrimental to its
w xsurvival, such as apoptosis 36 .
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